ListarArtículos (Medicina) por materia "Ibrutinib"
Mostrando ítems 1-1 de 1
-
Artículo
Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study)
(Elsevier, 2021)Ibrutinib demonstrated robust efficacy, regardless of high-risk features, in previously untreated or relapsed/refractory ...